Brookstone Capital Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$872K Sell
16,029
-5,129
-24% -$250K 0.01% 741
2026
Q1
$907K Buy
21,158
+5,076
+32% +$218K 0.01% 677
2025
Q4
$705K Buy
16,082
+66
+0.4% +$2.73K 0.01% 741
2025
Q3
$661K Buy
+16,016
New +$644K 0.01% 734

Other funds holding EXEL

Brookstone Capital Management's EXEL Position: Q2 2026 in Review

Brookstone Capital Management reduced its Exelixis (EXEL) stake by 24% in Q2 2026, selling an estimated $250K and leaving 16,029 shares worth $872K. The position accounts for 0.01% of the portfolio, ranked #741.

Brookstone Capital Management first reported a position in EXEL in Q3 2025 and has held it in 4 quarters since. The position peaked at $907K in Q1 2026. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Brookstone Capital Management held 16,029 shares of Exelixis worth $872K as of Q2 2026.
  • Brookstone Capital Management sold 5,129 Exelixis shares in Q2 2026, an estimated $250K.
  • Exelixis made up 0.01% of Brookstone Capital Management's portfolio in Q2 2026, its #741 holding.
  • Brookstone Capital Management first reported a position in Exelixis in Q3 2025 and has held it in 4 quarters since.
  • Brookstone Capital Management's Exelixis position peaked at $907K in Q1 2026.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.